Haoyuan Chemexpress CPhI China 2018 has successfully concluded

Number of visits:1766 Date:2018-06-22

20-22 June 2018, CPhI China 2018 and P-MEC China 2018 set off a strong new wave of medicine at Shanghai New International Expo Centre. The exhibition had thirteen 13 parts, including pharmaceutical raw materials, biopharmaceuticals, contract customization and so on, and attracting more than 60,000 professionals from home and abroad. That created an annual industry feast for the global pharmaceutical industry.

Haoyuan Chemexpress is mainly engaged in development, production, sales of novel compounds, API and advanced intermediates for generic drugs. As a fast growing CRO & CDMO company, we have established the R&D platform centering on featured APIs, to provide customers with full services ranging from research, manufacture to registration.

Our booth No. is W4F06. Many new and old customers and professionals come to advisory and negotiate in the show. Haoyuan Chemexpress learned more about the latest technologies in the industry through the exhibition forum. In addition, we had all-round and deep level exchanges with old and new customers. Many professionals were highly affirmed with our products, and hope to collaborative development with Haoyuan Chemexpress.

The exhibition provided strong support for Haoyuan Chemexpress to further join hands with global resources and enhance its international competitiveness. We will accelerate integration into the global pharmaceutical industry chain and achieve an international strategic upgrade after the exhibition. We will continuing to take orders the business philosophy of " All for Innovation, All for Custormers". Haoyuan Chemexpress will be on a higher level of R&D innovation driving platform, constantly providing customers with the best quality products and services, and maximizing customer value. At the same time, Haoyuan Chemexpress will continue to deepen the road to internationalization, becoming a more professional, international, high-end pharmaceutical company, toward a more internationally competitive, world-class pharmaceutical company!

Back to top